• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nightingale Health

0.96 EUR+2.13 %19/8 15:26
4,759 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
+2.13 %
+11.37 %
+0.63 %
-42.65 %
-53.17 %
-58.08 %
+19.40 %
-81.66 %
-81.36 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
58.5M EUR
Turnover
133.89K EUR
P/E (adj.) (26e)
-3.35
EV/EBIT (adj.) (26e)
-1.04
P/B (26e)
1.13
EV/S (26e)
3.13
Dividend yield-% (26e)
-
Coverage
Recommendation
Buy
Target price
1.40 EUR
Updated
2026-06-11
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 2026-06-12

Latest extensive report

Released: 2025-06-13

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
The home test apparently utilized by Supernormal was, from a consumer’s perspective, a quite functional and convenient service that I would still be willing to pay for today. During the pilot phase, I was able to conduct several home tests between 2021 and 2022. Now, a few years ...
yesterday
by Yariskuski
18
Boy, there are a lot of press releases coming out now… US Healthcare Business Executive Hugh Watson Appointed as Chief Commercial Officer for Americas at Nightingale Health - Inderes Changes in the Management Team of Nightingale Health Plc - Inderes
7 hours ago
by Tuuukka
14
Inderes Nightingale Healthin Remote Health Check osaksi Supernormalin lääkkeellistä... Nightingale Health Oyj | Lehdistötiedote | 18.08.2026 klo 09:57:00 EESTNightingale Health ja Supernormal ovat solmineet kumppanuuden, jonka myötä Nightingale Healthin Remote Health Check tulee....
yesterday
by Pertti
14
This is a reasonably positive sign, as Boston Heart Diagnostics is already a strategic partner of Nightingale, meaning someone is switching sides to a small Finnish company.
7 hours ago
by NukkeNukuttaja
12
Inderes – 19 Aug 26 Nightingalen etätestit osaksi Supernormalin painonhallintapalvelua - Inderes Yli 10 000 jäsenen Supernormal-yhteistyö vie etätestit osaksi GLP-1-lääkehoitoja.
9 hours ago
by Pertti
9
Inderes – 18 Aug 26 Nightingalelle uusi kumppanuus Isossa-Britanniassa - Inderes Kumppanuus avaa latua Ison-Britannian yksityisen terveydenhuollon markkinalla.
yesterday
by Pertti
9
He already knew the company, so he knew exactly what he was getting into. A good sign.
3 hours ago
by Pertti
4
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16/9
2026

Annual report '26

5/11
2026

General meeting '26

9/3
2027

Interim report Q2'27

Regulatory press release2026-08-19 08:00

Changes in Nightingale Health Plc's management team

Nightingale Health
Press release2026-08-19 08:00

US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas

Nightingale Health
Nightingale's remote tests to be included in Supernormal's weight loss service
Analyst Comment2026-08-19 09:12 by
Antti Siltanen

Nightingale's remote tests to be included in Supernormal's weight loss service

The Supernormal collaboration, with over 10,000 users, integrates remote testing into GLP-1 medication treatments.

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-08-18 08:57

Nightingale Health and Supernormal partner to bring at-home blood testing to medical weight loss in Finland

Nightingale Health
New partnership for Nightingale in the UK
Analyst Comment2026-08-18 09:18 by
Antti Siltanen

New partnership for Nightingale in the UK

The partnership paves the way in the UK private healthcare market.

Nightingale Health
Press release2026-08-17 10:30

Nightingale Health and Personalised Health Clinics collaborate on preventive metabolic health in the UK

Nightingale Health
Press release2026-07-01 15:00

Nightingale Health and Archipelago Health partner to bring preventive screening to small-island health systems in the Crown Dependencies, Bermuda and the Caribbean

Nightingale Health
Regulatory press release2026-06-29 17:15

Nightingale Health’s Board of Directors resolved on new stock option program

Nightingale Health
Nightingale: We factored the project delay into our estimates
Research2026-06-12 09:20 by
Antti Siltanen, Antti Luiro

Nightingale: We factored the project delay into our estimates

The revenue outlook for the next fiscal year exceeds 10 MEUR.

Nightingale Health
Nightingale's profit warning: Project delay shifts revenue to next year
Analyst Comment2026-06-09 08:40 by
Antti Siltanen

Nightingale's profit warning: Project delay shifts revenue to next year

The company's business appears to be progressing in line with our estimates.

Nightingale Health
Regulatory press release2026-06-08 18:25

Inside information, profit warning: Nightingale Health continues to grow but will not reach its 50% growth target this financial year as about EUR 2 million of revenue shifts to next financial year

Nightingale Health
Nightingale: Nightingale sings to a deaf market
Research2026-06-04 08:36 by
Antti Siltanen

Nightingale: Nightingale sings to a deaf market

The low valuation compensates for the very high level of risk.

Nightingale Health
Nightingale joins wellbeing services county research project
Analyst Comment2026-05-29 08:46 by
Antti Siltanen

Nightingale joins wellbeing services county research project

Nightingale's risk screening selects participants for lifestyle coaching.

Nightingale Health
Press release2026-05-28 10:00

Nightingale Health joins South Savo Wellbeing Services County's preventive healthcare research project in Finland

Nightingale Health
Regulatory press release2026-05-27 15:45

Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2026–2027

Nightingale Health
New partnership for Nightingale
Analyst Comment2026-05-25 08:11 by
Antti Siltanen

New partnership for Nightingale

The new memorandum of understanding will expand blood analysis to the longevity programs in Switzerland and South Africa as early as this summer.

Nightingale Health
Press release2026-05-22 08:30

Nightingale Health and Formula 100 Health partner in preventive health: Embedding multi-disease risk detection across longevity programmes in Switzerland and South Africa

Nightingale Health
Regulatory press release2026-05-21 16:25

Nightingale Health Plc – Managers’ Transactions – Olli Karhi

Nightingale Health
Regulatory press release2026-05-18 12:02

Nightingale Health Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)

Nightingale Health
US market roadmap for medical devices – a European perspective
Analyst Comment2026-03-27 11:45 by
Antti Siltanen

US market roadmap for medical devices – a European perspective

Success in the US requires success in several sub-areas.

BioretecAiforia TechnologiesNightingale HealthNexstimOptomedRevenio GroupModulightBiohit